| Literature DB >> 32682442 |
Lisa Affengruber1,2, Gernot Wagner3, Siw Waffenschmidt4, Stefan K Lhachimi5,6, Barbara Nussbaumer-Streit3, Kylie Thaler7, Ursula Griebler3, Irma Klerings3, Gerald Gartlehner3,8.
Abstract
BACKGROUND: Decision-makers increasingly request rapid answers to clinical or public health questions. To save time, personnel, and financial resources, rapid reviews streamline the methodological steps of the systematic review process. We aimed to explore the validity of a rapid review approach that combines a substantially abbreviated literature search with a single-reviewer screening of abstracts and full texts using three case studies.Entities:
Keywords: Evidence synthesis; Health care decision-making; Rapid review; Systematic review
Mesh:
Year: 2020 PMID: 32682442 PMCID: PMC7368980 DOI: 10.1186/s13643-020-01413-7
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Overview of the Cochrane reviews used as reference standards
| Case study | Author, year of publication | Cochrane review title | Aim | Number of studies (number of publications) included in the Cochrane review |
|---|---|---|---|---|
| 1 | Goldkuhle et al. 2018 [ | Nivolumab for adults with Hodgkin’s lymphoma Hematological malignancies group | To assess the benefits and harms of nivolumab in adult individuals with Hodgkin’s lymphoma | 3 (26) |
| 2 | Kunath et al. 2019 [ | Early versus deferred androgen suppression for treating advanced prostate cancer Urology group | To assess the effects of early versus deferred androgen suppression therapy for advanced hormone-sensitive prostate cancer | 10 (53) |
| 3 | Pega et al. 2017 [ | Unconditional cash transfers for reducing poverty and vulnerabilities Public health group | To assess the effect of unconditional cash transfers for reducing poverty and vulnerabilities on the use of health services and health outcomes in children and adults in low- and middle-income countries | 21 (68) |
Fig. 1Flow chart of the rapid review literature search and identification process
Characteristics of the Cochrane reviews used as reference standards
| Case study 1: Nivolumab for adult individuals with Hodgkin’s lymphoma [ | Case study 2: Early versus deferred androgen suppression for treating advanced prostate cancer [ | Case study 3: Unconditional cash transfers for reducing poverty and vulnerabilities [ | |
|---|---|---|---|
| October 2017 to May 2018 | January 23, 2018 | May 2, 2017 | |
| 675 | 19,380 | 30,453 | |
| 626 | 19,253 | 30,270 | |
| 49 | 127 | 183 | |
| 23 | 74 | 115 | |
| 26 (4) | 53 (34) | 68 (11) | |
| 3 (3) | 10 (10) | 21 (7) | |
| 0 | 10 | 11 | |
| 2 | 3 | 2 |
Characteristics of the rapid reviews
| Case study 1: Nivolumab for adult individuals with Hodgkin’s lymphoma | Case study 2: Early versus deferred androgen suppression for treating advanced prostate cancer | Case study 3: Unconditional cash transfers for reducing poverty and vulnerabilities | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | |
May 24, 2017 December 08, 2017 (update search) | July 19, 2017 | July 10, 2017 | |||||||
| 98 | 195 | 385 | |||||||
| 1 | 0 | 2 | 2 | 1 | 9 | 49 | 2 | 9 | |
| 99 | 98 | 100 | 197 | 196 | 204 | 434 | 387 | 394 | |
| 94 | 84 | 88 | 182 | 183 | 190 | 337 | 342 | 331 | |
| 5 | 14 | 12 | 15 | 13 | 14 | 97 | 45 | 63 | |
| 2 | 11 | 7 | 4 | 5 | 4 | 54 | 22 | 37 | |
| 3 | 3 | 4 | 7 | 6 | 7 | 15 | 9 | 12 | |
| 3 | 3 | 3 | 6 | 4 | 5 | 10 | 8 | 9 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 4 | 3 | 3 | |
| 0 | 0 | 0 | 3 | 5 | 4 | 1 | 2 | 1 | |
| 0 | 0 | 0 | 6 | 4 | 5 | 6 | 4 | 6 | |
Fig. 2Proportion of the identified publications and studies for case study 1 (oncological)
Fig. 3Proportion of the identified publications and studies for case study 2 (oncological)
Fig. 4Proportion of the identified publications and studies for case study 3 (public health)